[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$rhhby
Roche's Giredestrant shows a XX% reduced risk of recurrence or death in Phase X breast cancer trials, potentially offering a new oral alternative to injectables. The company also received EU approval for Gazyvaro in lupus nephritis, signaling advancements in multiple therapeutic areas.
About $rhhby
This topic refers to the decentralized digital currency and its associated blockchain technology.
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +49%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-03-12
1-Year Low: XXXXX on 2025-01-26
Engagements by network (24h): X: XXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXX +129%
X Year: XXXXX +97%
1-Year High: XXX on 2025-08-03
1-Year Low: XX on 2025-01-27
Mentions by network (24h): X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $rhhby in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXX -XX%
X Year: XXX +20%
1-Year High: XXX on 2025-03-06
1-Year Low: XX on 2025-09-15
The most influential creators that mention $rhhby in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @JacobPlieth | X | XXXXXX | X | XXXXX |
| @MethOSilly | X | XX | X | XXX |
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @Roche | X | XXXXXXX | X | XXX |
| @bioinvestor24 | X | XXXXX | X | XX |
| @Quantumup1 | X | XXXXX | X | XX |
| @OzmosiHealth | X | XXXXX | X | XX |
| @yusufhameed | X | XXXXX | X | XX |
| @yachmod | X | XXX | X | X |
| @Andre_AGTC | XX | XXXXX | X | X |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% +5%
X Months: XX% +18%
X Year: XX% -X%
1-Year High: XXX% on 2025-01-27
1-Year Low: XX% on 2025-08-09
Most Supportive Themes:
- Community Building: (40%) Focus on fostering a strong and engaged community around the topic.
- Educational Content: (30%) Providing valuable information and learning opportunities for the audience.
- Positive Reinforcement: (20%) Highlighting successes and encouraging continued participation.
Most Critical Themes:
- Market Volatility: (60.5%) Significant fluctuations in the market are causing concern among investors.
- Regulatory Uncertainty: (39.5%) Unclear future regulations are creating apprehension and impacting investment decisions.
Top $rhhby Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Shock $LLY reveals Inluriyo + Verzenio combo filing in ESR1m only despite showing #SABCS25 promise in ESR1w/t. Scoop via @ApexOnco - $RHHBY $AZN $ARVN $OLMA"
X Link @JacobPlieth 2025-12-12T16:55Z 31.3K followers, 4805 engagements
"So where does this the #tigit Fc debate Fc-active: $GSK $ITOS fail $MRK fail $RHHBY fail Fc-silent: $RCUS $GILD fail Fc-reduced: $AZN $CGEN"
X Link @JacobPlieth 2025-12-12T15:03Z 31.3K followers, 1598 engagements
"$SGMO #chronicpain #nonopioid #Fabry #HemA $LLY $ABBV $AZN $ALPMY $RHHBY $VRTX $PFE MethO a renown collector of delicious Sangamo shares. He just cant stop adding 💎😎💎"
X Link @MethOSilly 2025-12-12T14:20Z XX followers, XXX engagements
"After $RHHBY #Tigit failed in Skyscraper-14 $RCYS $GILD terminate Star-221 for futility. Evidently someone was surprsed as $RCUS is -XX% PM"
X Link @JacobPlieth 2025-12-12T13:58Z 31.3K followers, 2535 engagements